Saltar al contenido
Merck

Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma.

Scandinavian journal of plastic and reconstructive surgery and hand surgery (2003-12-03)
Christoffer Ingves, Gregor B E Jemec
RESUMEN

We report the successful outcome of treatment of a basal cell carcinoma (BCC) with topical imiquimod and systemic acitretin in a 48-year-old woman. We think that this treatment is a possible option for management of these non-life-threatening tumours. Experimental evidence suggests that combination treatment with retinoids increase the effects of imiquimod and would therefore seem to be possible when treating superficial tumours in areas where the cosmetic outcome is particularly important.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Acitretin, ≥98.0% (HPLC)
USP
Acitretin, United States Pharmacopeia (USP) Reference Standard
Acitretin, European Pharmacopoeia (EP) Reference Standard